Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2008 Oct 30;359(18):1885-96.
doi: 10.1056/NEJMoa0803024.

Aggressive vs. conservative phototherapy for infants with extremely low birth weight

Collaborators, Affiliations
Randomized Controlled Trial

Aggressive vs. conservative phototherapy for infants with extremely low birth weight

Brenda H Morris et al. N Engl J Med. .

Abstract

Background: It is unclear whether aggressive phototherapy to prevent neurotoxic effects of bilirubin benefits or harms infants with extremely low birth weight (1000 g or less).

Methods: We randomly assigned 1974 infants with extremely low birth weight at 12 to 36 hours of age to undergo either aggressive or conservative phototherapy. The primary outcome was a composite of death or neurodevelopmental impairment determined for 91% of the infants by investigators who were unaware of the treatment assignments.

Results: Aggressive phototherapy, as compared with conservative phototherapy, significantly reduced the mean peak serum bilirubin level (7.0 vs. 9.8 mg per deciliter [120 vs. 168 micromol per liter], P<0.01) but not the rate of the primary outcome (52% vs. 55%; relative risk, 0.94; 95% confidence interval [CI], 0.87 to 1.02; P=0.15). Aggressive phototherapy did reduce rates of neurodevelopmental impairment (26%, vs. 30% for conservative phototherapy; relative risk, 0.86; 95% CI, 0.74 to 0.99). Rates of death in the aggressive-phototherapy and conservative-phototherapy groups were 24% and 23%, respectively (relative risk, 1.05; 95% CI, 0.90 to 1.22). In preplanned subgroup analyses, the rates of death were 13% with aggressive phototherapy and 14% with conservative phototherapy for infants with a birth weight of 751 to 1000 g and 39% and 34%, respectively (relative risk, 1.13; 95% CI, 0.96 to 1.34), for infants with a birth weight of 501 to 750 g.

Conclusions: Aggressive phototherapy did not significantly reduce the rate of death or neurodevelopmental impairment. The rate of neurodevelopmental impairment alone was significantly reduced with aggressive phototherapy. This reduction may be offset by an increase in mortality among infants weighing 501 to 750 g at birth. (ClinicalTrials.gov number, NCT00114543.)

PubMed Disclaimer

Conflict of interest statement

Dr. Fanaroff reports receiving consulting fees, and Dr. Guillet grant support, from Natus. No other potential conflict of interest relevant to this article was reported.

Figures

Figure 1
Figure 1. Enrollment, Randomization, and Follow-up of the Study Patients
There were no significant differences at baseline between infants with known and those with unknown neurodevelopmental status.

References

    1. Bratlid D. How bilirubin gets into the brain. Clin Perinatol. 1990;17:449–65. - PubMed
    1. Cashore WJ. The neurotoxicity of bilirubin. Clin Perinatol. 1990;17:437–47. - PubMed
    1. Lucey JF. Bilirubin and brain damage — a real mess. Pediatrics. 1982;69:381–2.
    1. Watchko JF, Oski FA. Kernicterus in preterm newborns: past, present, and future. Pediatrics. 1992;90:707–15. - PubMed
    1. Boggs TR, Jr, Hardy JB, Frazier TM. Correlation of neonatal serum total bilirubin concentrations and developmental status at age eight months: a preliminary report from the Collaborative Project. J Pediatr. 1967;71:553–60. - PubMed

Publication types

Associated data

Grants and funding